相关实验视频
Updated: Jun 26, 2025

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.5K
[抗环素引起的心力衰竭:治疗和康复前景]
M V Vitsenya1, A V Potekhina1, A Yu Filatova1
1Chazov National Medical Research Center of Cardiology, Moscow.
Kardiologiia
|May 14, 2024
概括
抗环素化疗可以导致心力衰竭,即使在患有低心血管风险的乳腺癌患者. 这一案例凸显了在癌症治疗期间监测心脏功能的重要性.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 人环素是乳腺癌的有效化疗剂.
- 心脏毒性是一种已知的反环素治疗的副作用.
- 在接受治疗的癌症患者中,评估心血管风险至关重要.
研究的目的:
- 报告一个乳腺癌患者心力衰竭的病例,该患者正在接受 antracycline 治疗.
- 突出最初心血管风险较低的患者心脏毒性潜力.
- 强调在抗瘤治疗期间需要警的心脏监测.
主要方法:
- 临床病例的介绍.
- 审查患者的病史和治疗方案.
- 心血管评估和监测.
主要成果:
- 患者在含有 antracycline 的抗瘤疗法期间出现心力衰竭.
- 该患者最初的心血管并发症风险很低.
- 尽管风险较低,但心脏功能障碍发生.
结论:
- 人环素治疗可以导致心力衰竭,即使在被认为低风险的患者中也是如此.
- 在乳腺癌患者中,早期发现和治疗心脏毒性是必不可少的.
- 这一案例强调了在瘤学中全面的心脏监测的重要性.
相关概念视频
Heart Failure Drugs: Inotropic Agents
573
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
573
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Heart Failure Drugs: Diuretics
367
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
367
Exercise and Cardiovascular Response
791
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
791
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K

